BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1641762)

  • 1. Neuropeptide release from the isolated, perfused, lower esophageal sphincter region of the rabbit and the effect of vasoactive intestinal peptide on the sphincter.
    Yamashita Y; Kako N; Homma K; Hirai T; Hinder RA; DeMeester TR; Toge T; Adrian TE
    Surgery; 1992 Aug; 112(2):227-33; discussion 233-4. PubMed ID: 1641762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin selectively inhibits excitatory contractile pathways of the feline lower esophageal sphincter.
    Parkman HP; Reynolds JC
    Regul Pept; 1990 Mar; 27(3):325-34. PubMed ID: 1691517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation.
    Biancani P; Walsh JH; Behar J
    J Clin Invest; 1984 Apr; 73(4):963-7. PubMed ID: 6142903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia.
    Guelrud M; Rossiter A; Souney PF; Rossiter G; Fanikos J; Mujica V
    Gastroenterology; 1992 Aug; 103(2):377-82. PubMed ID: 1634056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide: a sensory and motor neurotransmitter in the feline lower esophageal sphincter.
    Parkman HP; Reynolds JC; Elfman KS; Ogorek CP
    Regul Pept; 1989 Apr; 25(1):131-46. PubMed ID: 2470120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of various peptides on isolated rabbit lower esophageal sphincter.
    Kohjitani A; Shirakawa J; Okada S; Obara H
    Peptides; 1996; 17(6):927-31. PubMed ID: 8899810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic relaxation of the opossum lower esophageal sphincter: roles of NO., VIP, and CGRP.
    Uc A; Oh ST; Murray JA; Clark E; Conklin JL
    Am J Physiol; 1999 Sep; 277(3):G548-54. PubMed ID: 10484379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter.
    Rattan S; Moummi C
    J Pharmacol Exp Ther; 1989 Feb; 248(2):703-9. PubMed ID: 2537411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization and inhibitory actions of galanin at the feline lower esophageal sphincter.
    Lichtenstein GR; Reynolds JC; Ogorek CP; Parkman HP
    Regul Pept; 1994 Mar; 50(3):213-22. PubMed ID: 7517056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric somatostatin release: evidence for direct mediation by calcitonin gene-related peptide and vasoactive intestinal peptide.
    Zdon MJ; Adrian TE; Modlin IM
    J Surg Res; 1988 Jun; 44(6):680-6. PubMed ID: 2898038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium source diversity in canine lower esophageal sphincter muscle.
    Salapatek AM; Lam A; Daniel EE
    J Pharmacol Exp Ther; 1998 Oct; 287(1):98-106. PubMed ID: 9765327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide and non-adrenergic, non-cholinergic inhibition in lower oesophageal sphincter of opossum.
    Daniel EE; Jager LP; Jury J
    Br J Pharmacol; 1989 Mar; 96(3):746-52. PubMed ID: 2720302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic characterization of intrinsic mechanisms controlling tone and relaxation of porcine lower esophageal sphincter.
    Farré R; Aulí M; Lecea B; Martínez E; Clavé P
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1238-48. PubMed ID: 16303917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of peptide histidine isoleucine in relaxation of cat lower esophageal sphincter.
    Biancani P; Beinfeld MC; Hillemeier C; Behar J
    Gastroenterology; 1989 Nov; 97(5):1083-9. PubMed ID: 2571542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasoactive intestinal peptide on resting and pentagastrin-stimulated lower esophageal sphincter pressure.
    Domschke W; Lux G; Domschke S; Strunz U; Bloom SR; Wünsch E
    Gastroenterology; 1978 Jul; 75(1):9-12. PubMed ID: 401103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
    Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
    Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasoactive intestinal polypeptide (VIP) on lower esophageal sphincter in awake baboons: comparison with glucagon and secretin.
    Siegel SR; Brown FC; Castell DO; Johnson LF; Said SI
    Dig Dis Sci; 1979 May; 24(5):345-9. PubMed ID: 110570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vasoactive intestinal polypeptide on the release of serotonin from the in vitro vascularly perfused small intestine of guinea pig.
    Schwörer H; Racké K; Kilbinger H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):540-5. PubMed ID: 2475786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and characterization of vasoactive intestinal polypeptide binding in canine lower esophageal sphincter.
    Mao YK; Wang YF; Daniel EE
    Gastroenterology; 1993 Nov; 105(5):1370-7. PubMed ID: 8224641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of hypochlorous acid on lower esophageal sphincter tone relaxation by vasoactive intestinal peptide.
    Park SY; Youm JH; Jung KC; Sohn UD
    Arch Pharm Res; 2008 Dec; 31(12):1552-8. PubMed ID: 19099223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.